PARMPREET GILL: Open Payments
NPI 1750932844 · ELK GROVE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,801 in 56 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,801
Food & beverage: $1,729Education: $72
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 13 | $416 |
| ABBVIE INC. | 8 | $246 |
| UCB, Inc. | 6 | $184 |
| LEO Pharma Inc. | 3 | $156 |
| GENZYME CORPORATION | 4 | $123 |
| Botanix SB Inc | 1 | $122 |
| Regeneron Healthcare Solutions, Inc. | 4 | $122 |
| Janssen Biotech, Inc. | 3 | $78 |
| SANOFI-AVENTIS U.S. LLC | 1 | $72 |
| Arcutis Biotherapeutics, Inc. | 3 | $69 |
Products named: OPZELURA, DUPIXENT, SKYRIZI, ANZUPGO, SOFDRA, TREMFYA, Bimzelx, Zoryve.
Industry payments across CA — which companies pay providers there.
